AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 157 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $49,000 | -56.6% | 3,307 | -78.3% | 0.00% | – |
| Q2 2022 | $113,000 | +82.3% | 15,225 | +121.8% | 0.00% | – |
| Q1 2022 | $62,000 | +72.2% | 6,863 | +33.9% | 0.00% | – |
| Q4 2021 | $36,000 | -62.1% | 5,124 | -38.5% | 0.00% | – |
| Q3 2021 | $95,000 | -10.4% | 8,337 | +26.1% | 0.00% | – |
| Q2 2021 | $106,000 | -17.2% | 6,614 | -7.8% | 0.00% | – |
| Q1 2021 | $128,000 | +17.4% | 7,171 | -12.0% | 0.00% | – |
| Q4 2020 | $109,000 | -47.8% | 8,152 | -53.9% | 0.00% | -100.0% |
| Q3 2020 | $209,000 | +226.6% | 17,688 | +308.4% | 0.00% | – |
| Q2 2020 | $64,000 | +220.0% | 4,331 | +214.8% | 0.00% | – |
| Q1 2020 | $20,000 | – | 1,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |